Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19
Listen now
Description
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
More Episodes
Interview with Daniel Grossman, MD, author of Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening, and Emily M. Godfrey, MD, MPH, author of Primary Care’s Role in Prescribing Mail-Order Mifepristone. Hosted by Eve Rittenberg, MD. Related Content: ...
Published 05/13/24
Interview with Chintan V. Dave, PharmD, PhD, author of Antihypertensive Medication and Fracture Risk in Older Veterans Health Administration Nursing Home Residents, and Muna Thalji Canales, MD, MS, author of Blood Pressure Management and Falls in Nursing Home Residents—A Matter of Balance. Hosted...
Published 04/22/24